Fortrea Holdings Inc.

NASDAQ:FTRE

Biotechnology

Healthcare
$20.50 -0.46%

-$0.07 today

Market cap
$1.94B
Beta
2.11
P/E (TTM)
-3.1
EPS (TTM)
-$4.90
52W Low $4.36High $18.67

Volume 1.59M

Average 1.31M

FTRE Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Fortrea Holdings Inc.NASDAQ: FTRE

Gross Margin · Q2 FY2026 · quarter ended Jun 2026

Gross margin widens to 20.5%

Gross margin was 20.5% in Q2 FY2026, up 4.5 pp from a year earlier. On a trailing-twelve-month basis it was 17.1%, down 1.9 pp year over year. Over 3 fiscal years it narrowed by 9.9 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
20.5%+4.2 pp QoQ
Last fiscal yearDec 2025
15.6%-4.2 pp YoY
LTMJun 2026
17.1%-1.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.5 pp——
1 year-4.2 pp——
3 years-9.9 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
15.6%
Year-over-year change
-4.2pp

Gross Margin vs competitors

How FTRE compares with its peers on the latest reported figures

  • FTRE's LTM Jun 2026 gross margin of 17.1% is the lowest of the 3 companies compared; the peer median is 43.6%.
  • Its year-over-year change of -1.9 pp is the highest of 3, against a peer median of -2.1 pp.
  • Over three fiscal years its change of -9.9 pp compares with a peer median of +0.7 pp.
FTRE Competitors Peer median
Gross Margin for FTRE and competitors
Company Period LTM level YoY 3-year change
CERTCertara, Inc.LTM Mar 202658.1% -2.1 pp+1.0 pp
MEDPMedpace Holdings, Inc.LTM Sep 202629.1% -2.0 pp+0.4 pp
FTREFortrea Holdings Inc.LTM Jun 202617.1% -1.9 pp-9.9 pp
Peer median (excluding FTRE) 43.6%-2.1 pp+0.7 pp

Competitors are the stored peer set for FTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.06B2.84B2.84B2.7B2.72B
Cost of Revenue2.45B2.11B2.25B2.16B2.3B
Gross Profit604.4M724.4M590.6M534.2M425.8M
Gross Margin19.8%25.5%20.8%19.8%15.6%
Research & Development00000
Selling, General & Admin303.1M416.1M448.1M560.7M456.4M
Operating Expenses490.1M537.3M558.6M696.1M456.4M
Depreciation & Amortization166.3M93.6M98M86.9M78M
EBITDA302.9M280.8M137.2M(64.3M)(813.6M)
EBITDA Margin9.9%9.9%4.8%-2.4%-29.9%
Operating Income114.3M187.1M32M(161.9M)(30.6M)
Operating Margin3.7%6.6%1.1%-6.0%-1.1%
Interest Income00000
Interest Expense200K200K69.8M123.8M91.4M
Other Income / Expenses22.1M(100K)(62.5M)(113.1M)(952.4M)
Income Before Tax136.4M187M(30.5M)(275M)(983M)
Pre-Tax Margin4.5%6.6%-1.1%-10.2%-36.1%
Income Tax Expense38.4M41.1M1.2M(3.5M)3.2M
Net Income98M186.2M(25.2M)(328.5M)(986.2M)
Net Margin3.2%6.6%-0.9%-12.2%-36.2%
EPS (Basic)1.112.11(0.04)(3.67)(10.81)
EPS (Diluted)1.112.11(0.04)(3.67)(10.81)
Weighted Avg Shares88.4M88.4M88.8M89.5M91.2M
Weighted Avg Shares (Diluted)88.4M88.4M88.8M89.5M91.2M

Fortrea Holdings Inc.

NASDAQ:FTRE

Intrinsic Alpha fair value

Locked

Current Price

$20.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.